Correction to: Cardiovasc Diabetol (2017) 16:65 10.1186/s12933-017-0547-1
Following publication of the original article [1] the authors reported that the first affiliation (“Medical Center of the Graduate School, Nanchang University, China”) had been added in error, and that the correct author information is as given in this erratum.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Footnotes
Honghong Zou and Baoqin Zhou contributed equally to this work
The original article can be found online at https://doi.org/10.1186/s12933-017-0547-1.
Reference
- 1.Zou H, Zhou B, Gaosi X. SGLT2 inhibitors: a novel choice for the combination therapy in diabetic kidney disease. Cardiovasc Diabetol. 2017;16:65. doi: 10.1186/s12933-017-0547-1. [DOI] [PMC free article] [PubMed] [Google Scholar]